Literature DB >> 7103547

Long-term outcome of primary nephrotic syndrome.

O Koskimies, J Vilska, J Rapola, N Hallman.   

Abstract

One hundred and fourteen children with primary nephrotic syndrome were followed up prospectively for periods of between 5 and 14 years. Urine samples from 94 of them became protein-free during the initial 8-week course of prednisone, and the outcome for these children was good: 74 of them have been free of symptoms for at least 3 years, 18 have had relapses during the last 3 years, and only one child still has proteinuria. All these children have normal renal function and blood pressure. One child died accidentally. Twenty children did not respond to the initial prednisone treatment. Thirteen of them had remissions later, of whom 2 have had relapses during the last 3 years. Seven were totally resistant to prednisone 4 of whom died in renal failure, the remaining 3 have persistent proteinuria with normal levels of creatinine; one has high blood pressure too. Remission during the initial treatment indicated a good prognosis, but two-thirds of the initial non-responders also fared well.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7103547      PMCID: PMC1627702          DOI: 10.1136/adc.57.7.544

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Long-term follow-up of children with steroid-responsive nephrotic syndrome.

Authors:  N J Siegel; B Goldberg; L S Krassner; J P Hayslett
Journal:  J Pediatr       Date:  1972-08       Impact factor: 4.406

2.  A 16-year follow-up study of 163 children with nephrotic syndrome.

Authors:  M W Schwartz; G J Schwartz; D Cornfeld
Journal:  Pediatrics       Date:  1974-11       Impact factor: 7.124

Review 3.  The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases.

Authors:  R Habib; C Kleinknecht
Journal:  Pathol Annu       Date:  1971

4.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

  4 in total
  65 in total

1.  Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

Authors:  Pavel Geier; Amani Roushdi; Sylva Skálová; Jennifer Vethamuthu; Gabrielle Weiler; Janusz Feber
Journal:  Pediatr Nephrol       Date:  2012-06-24       Impact factor: 3.714

Review 2.  Evidence-based management of steroid-sensitive nephrotic syndrome.

Authors:  Elisabeth M Hodson; Jonathan C Craig; Narelle S Willis
Journal:  Pediatr Nephrol       Date:  2005-06-21       Impact factor: 3.714

3.  Clinical features and outcome of childhood minimal change nephrotic syndrome: is genetics involved?

Authors:  Anne-Tiina Lahdenkari; Maija Suvanto; Eero Kajantie; Olli Koskimies; Marjo Kestilä; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2005-06-21       Impact factor: 3.714

4.  Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome.

Authors:  A R Kreeftmeijer-Vegter; T P C Dorlo; M P Gruppen; A de Boer; P J de Vries
Journal:  Br J Clin Pharmacol       Date:  2015-06-05       Impact factor: 4.335

Review 5.  Modern management of nephrotic syndrome.

Authors:  K K Kher; S P Makker; M Sweet
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

6.  Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.

Authors:  Rodney D Gilbert; Eleanor Hulse; Susan Rigden
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

Review 7.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Narelle S Willis; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2015-03-18

8.  Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.

Authors:  Antonia Peña; Juan Bravo; Marta Melgosa; Carlota Fernandez; Carmen Meseguer; Laura Espinosa; Angel Alonso; M Luz Picazo; Mercedes Navarro
Journal:  Pediatr Nephrol       Date:  2007-09-18       Impact factor: 3.714

9.  Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Authors:  Sarah J Swartz; Karen W Eldin; M John Hicks; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2009-02-14       Impact factor: 3.714

10.  Primary nephrotic syndrome in Arab children.

Authors:  A Y Elzouki; F Amin; O P Jaiswal
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.